0001479290-19-000103.txt : 20191015
0001479290-19-000103.hdr.sgml : 20191015
20191015202304
ACCESSION NUMBER: 0001479290-19-000103
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191013
FILED AS OF DATE: 20191015
DATE AS OF CHANGE: 20191015
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Foley Mark J
CENTRAL INDEX KEY: 0001529196
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36297
FILM NUMBER: 191151870
MAIL ADDRESS:
STREET 1: ZELTIQ AESTHETICS INC.
STREET 2: 4698 WILLOW ROAD SUITE 100
CITY: PLEASANTON
STATE: CA
ZIP: 94588
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Revance Therapeutics, Inc.
CENTRAL INDEX KEY: 0001479290
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770551645
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7555 GATEWAY BLVD.
CITY: NEWARK
STATE: CA
ZIP: 94560
BUSINESS PHONE: 510-742-3400
MAIL ADDRESS:
STREET 1: 7555 GATEWAY BLVD.
CITY: NEWARK
STATE: CA
ZIP: 94560
4
1
wf-form4_157118535567459.xml
FORM 4
X0306
4
2019-10-13
0
0001479290
Revance Therapeutics, Inc.
RVNC
0001529196
Foley Mark J
C/O REVANCE THERAPEUTICS, INC.
7555 GATEWAY BLVD.
NEWARK
CA
94560
1
1
0
0
CEO & President
Common Stock
2019-10-13
4
A
0
200000
0
A
213500
D
Common Stock
20000
I
See footnote
Employee Stock Option (Right to Buy)
12.18
2019-10-13
4
A
0
740000
0
A
2029-10-12
Common Stock
740000.0
740000
D
The shares subject to the Restricted Stock award shall vest in three (3) equal annual installments beginning from October 13, 2019, subject to Mr. Foley's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan (the "Plan")) on each vesting date.
These shares are held by the Mark and Dana Foley, Trustees, Foley Family Trust U/A DTD 4/10/2002.
The fair market value was determined on October 11,2019 pursuant to the Plan.
The Option vests in accordance to the following schedule: 25% of the shares subject to the Option shall vest on the first anniversary of the vesting commencement date of October 13, 2019, and 1/48th of the shares vesting each month thereafter for the remaining three years, subject to Mr. Foley's Continuous Service (as defined in the Plan) as of each such vesting date.
/s/ Gordon Ho, Attorney-in-Fact
2019-10-15